These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17029106)

  • 1. Identification of three novel peptides that inhibit CD40-CD154 interaction.
    Kitagawa M; Goto D; Mamura M; Matsumoto I; Ito S; Tsutsumi A; Sumida T
    Mod Rheumatol; 2005; 15(6):423-6. PubMed ID: 17029106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154.
    Deambrosis I; Lamorte S; Giaretta F; Tei L; Biancone L; Bussolati B; Camussi G
    J Mol Med (Berl); 2009 Feb; 87(2):181-97. PubMed ID: 18985310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Involvement of CD40-CD154 interaction in immunopathogenesis of collagen diseases and its application to a novel therapeutic strategy].
    Harigai M
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Dec; 27(6):379-88. PubMed ID: 15678891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.
    Toubi E; Shoenfeld Y
    Autoimmunity; 2004; 37(6-7):457-64. PubMed ID: 15621572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CD154 with different receptors and its role in bidirectional signals.
    Alturaihi H; Hassan GS; Al-Zoobi L; Salti S; Darif Y; Yacoub D; El Akoum S; Oudghiri M; Merhi Y; Mourad W
    Eur J Immunol; 2015 Feb; 45(2):592-602. PubMed ID: 25403978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
    Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
    J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40.
    Delmas Y; Viallard JF; Solanilla A; Villeneuve J; Pasquet JM; Belloc F; Dubus I; Déchanet-Merville J; Merville P; Blanco P; Pellegrin JL; Nurden AT; Combe C; Ripoche J
    Kidney Int; 2005 Nov; 68(5):2068-78. PubMed ID: 16221206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD40-CD154 interaction in tissue fibrosis.
    Kawai M; Masuda A; Kuwana M
    Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory computational assessment of possible binding modes for small molecule inhibitors of the CD40-CD154 co-stimulatory interaction.
    Ganesan L; Vidović D; Schürer SC; Buchwald P
    Pharmazie; 2012 May; 67(5):374-9. PubMed ID: 22764566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display.
    Yu H; Segers F; Sliedregt-Bol K; Bot I; Woltman AM; Boross P; Verbeek S; Overkleeft H; van der Marel GA; van Kooten C; van Berkel TJ; Biessen EA
    FASEB J; 2013 Oct; 27(10):4136-46. PubMed ID: 23896727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Mavragani CP; Bourazopoulou E; Balitsari AV; Routsias JG
    Thromb Haemost; 2004 Dec; 92(6):1303-11. PubMed ID: 15583738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts.
    Fukasawa C; Kawaguchi Y; Harigai M; Sugiura T; Takagi K; Kawamoto M; Hara M; Kamatani N
    Eur J Immunol; 2003 Oct; 33(10):2792-800. PubMed ID: 14515263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel peptides specifically binding to endometriosis by screening phage-displaying peptide libraries.
    Chang CC; Hsieh YY; Wang YK; Hsu KH; Tsai HD; Tsai FJ; Lin CS
    Fertil Steril; 2009 Dec; 92(6):1850-5. PubMed ID: 19200967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.
    Howard LM; Ostrovidov S; Smith CE; Dal Canto MC; Miller SD
    J Clin Invest; 2002 Jan; 109(2):233-41. PubMed ID: 11805135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic dyes as small molecule protein-protein interaction inhibitors for the CD40-CD154 costimulatory interaction.
    Buchwald P; Margolles-Clark E; Kenyon NS; Ricordi C
    J Mol Recognit; 2010; 23(1):65-73. PubMed ID: 19621420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.
    Gong YF; Xiang LX; Shao JZ
    J Immunol; 2009 Jun; 182(12):7749-62. PubMed ID: 19494299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for CD40-directed experimental therapy of human cancer.
    Tong AW; Stone MJ
    Cancer Gene Ther; 2003 Jan; 10(1):1-13. PubMed ID: 12489023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.